Clarus Therapeutics, Inc. announced the hiring of Theodore M. Danoff, M.D., Ph.D. and Wael A. Salameh, M.D., FACP to fill the newly created posts of VP clinical development & chief medical officer and VP medical affairs & chief scientific officer, respectively. Dr. Danoff has been board certified in internal medicine and nephrology and has extensive pharmaceutical industry R&D experience at SmithKline Beecham, GlaxoSmithKline and, most recently, Endo Pharmaceuticals where he was vice president, clinical development and medical affairs. Dr. Salameh is board certified in internal medicine and endocrinology and has specialized training in andrology/men's health.

Prior to joining Clarus, Dr. Salameh was on the medical faculties of Temple University and UCLA. He left UCLA to become medical director, endocrinology, metabolism and cardiovascular laboratories at Quest Diagnostics Nichols Institute.